InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: TheMonolith post# 334

Thursday, 03/01/2018 3:45:53 PM

Thursday, March 01, 2018 3:45:53 PM

Post# of 430
COV was definitely ahead of itself based on what was/is publicly known, but I think this company is like an iceberg with a lot of technology hidden below the surface, or "in the lab" as Brian likes to say, so I only parted with a little during that run to $8 as well as I have a long-term holding here I believe could be worth much more if the company signs a licensing agreement for their coating technology or announces advancement of one of their other technologies we may not even know exists.

As far as sales growth goes, Brian mentioned the possibility of expanding the number of SKUs under the Saudi contracts. The company has also been making investments in the UK and recently got CovaWound products added to the Scottish Drug Tariff program in February 2018:
http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Scottish-Drug-Tariff/Amendments/Docs/2018/2018-02-SDT-AMD-v3.pdf?05:34:36

I also just found their Iranian distributor has a nice informative web presence:
http://m-s-f.ir/%D9%85%D9%82%D8%A7%D9%84%D8%A7%D8%AA-%D8%A7%D9%86%DA%AF%D9%84%DB%8C%D8%B3%DB%8C/?lang=en

It doesn't take much imagination to see there's still lots of room for growth here, it's just a matter of whether payors will be willing to pay for higher quality products.

"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854